Headlands Technologies’s RxSight RXST Stock Holding History

Headlands Technologies’s Portfolio RXST Stock Details RXST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-13,510	Closed	-$83.2K	–	952
2026 Q1	$83.2K	Buy	+13,510	New	+$112K	0.01%	676

Other funds holding RXST

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

No Street GP LP San Francisco, California $1.66B AUM 39.91% 1-Year Est. Return

Nomura Holdings Tokyo, Japan $85.4B AUM 91.09% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Headlands Technologies's RXST Position: Q2 2026 in Review

Headlands Technologies sold out of RxSight (RXST) in Q2 2026, closing a stake of 13,510 shares — an estimated $83.2K sold.

Headlands Technologies first reported a position in RXST in Q1 2026 and held it in 1 quarter. The position peaked at $83.2K in Q1 2026. 151 funds tracked by Wall St. Rank hold RXST as of Q2 2026.

Headlands Technologies reported no remaining RxSight position as of Q2 2026 after selling out during the quarter.
Headlands Technologies sold 13,510 RxSight shares in Q2 2026, an estimated $83.2K.
Headlands Technologies first reported a position in RxSight in Q1 2026 and held it in 1 quarter.
Headlands Technologies's RxSight position peaked at $83.2K in Q1 2026.
151 funds tracked by Wall St. Rank held RxSight as of Q2 2026.

Based on Headlands Technologies's 13F filing for Q2 2026, filed 13 Aug 2026.